AVANOS MEDICAL, INC. 8-K

What Happened Avanos Medical, Inc. (AVNS) filed a Current Report on Form 8-K on February 24, 2026 (Item 2.02) to announce its results of operations for the three months and the full fiscal year ended December 31, 2025. The company furnished a press release with those results as Exhibit 99.1 to the filing.

Key Details

• Filing date: February 24, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Period reported: three months and year ended December 31, 2025 (Q4 2025 and full-year 2025).
• Press release: furnished as Exhibit 99.1 to the 8-K; interactive XBRL cover page included as Exhibit 104.
• Form 8-K signed by John J. Hurley, Controller, on behalf of Avanos Medical.

Why It Matters This filing notifies investors that Avanos has publicly reported its quarterly and annual financial results; those figures (revenue, earnings, margins, cash flow and any company commentary) are included in the press release and could affect the stock and analyst expectations. Retail investors should review the attached press release (Exhibit 99.1) for the specific financial metrics, any management commentary on performance or outlook, and to see whether the results meet or miss prior guidance.